Project Premonition, a Microsoft Research project that uses drones to capture mosquitoes and analyze them for pathogens, preprint servers, and three mouse models for Zika virus induced birth defects are the topics of this episode hosted by the TWiumvirate and theirs guests Etha... Read More
The Zika virus, unlike other mosquito-borne viruses such as dengue, has until now been relatively unknown and unstudied. Read More
For the first time, researchers have found a person in the United States carrying bacteria resistant to antibiotics of last resort, an alarming development that the top U.S. public health official says could signal "the end of the road" for antibiotics.
The antibiotic-resistant strain was fou... Read More
Collaboration between two Texas Medical Center institutions has resulted in today's release of the country's first hospital-based rapid tests for the Zika virus. Read More
Highlights of the Recent Advances in Microbial Control meeting in San Diego, and expansion of a gut pathogen by virulence factors that stimulate aerobic respiration.
We hope you've started plating your dishes! Here are some of the 2016 entries thus far. Show us your creative streaking! For contest entry rules visit: www.microbeworl.org/art. Submissions close May 6, 2016 11:59 P.M.EST.Entries pictured from left to right: Symbol of ASM, A Once in a Lifetime Ki... Read More
The TWiP ternion solve the case of the Man from Mexico, and discuss a transgenic toxoplasma vaccine for chickens using Eimeria tenella.
Watch a panel of Zika virus experts who speak about the latest developments on Zika virus research and a wide range of fields that touch on flaviviruses.
Lynn Enquist, Ph. D.
ASM President and Zika conference convener, Henry L. Hillman Professor in Molecular Biology and Pro... Read More
Vincent speaks with David Tuller about flaws in the U.K's $8 million PACE trial for chronic fatigue syndrome, and efforts to have the trial data released.
Host: Vincent Racaniello
Gue... Read More
A scientific paper released today in the Journal of Drug Design, Development and Therapy show the effectiveness of Zolav®, a new antibiotic, in treating acne. Read More
In the first of two shows recorded at the University of North Carolina in Chapel Hill, Vincent meets up with faculty members to talk about how they got into science, their research on DNA viruses, and what they would be doing if they were not scientists.
Host: Read More
PRINCETON, N.J.--As world leaders grapple with containing the Zika virus, the Ebola epidemic in West Africa provides valuable lessons for how to respond to infectious disease epidemics, according to a policy report published by researchers at Princeton University and the Wellcome Trust. Read More
Host: Jeff Fox with special guests, Carolyn Shore and Ruben Tommasi.
Carolyn Shore of Pew Charitable Trusts in Washington, D.C., and Ruben Tommasi of Entasis Therapeutics in Waltham, Massachusetts, talk with Jeff Fox about what’s needed to identify and develop new antimicrobial agents... Read More
Washington, DC – August 17, 2016 – The multidrug-resistant yeast Candida auris, which has caused fatal infections in some hospitalized patients, has at least two different growth patterns and some of its strains are as capable of causing disease as the most invasive type of yeast called Candida ... Read More
In the 1960’s, the microbicide triclosan, was introduced in the United States, and soon after, human weight started to increase dramatically. For some time, researchers have wondered whether triclosan could have played a role in disrupting endocrine dysfunction and contributing to the obesity ep... Read More
The TWiPtoids solve the case of the Thai Fisherman with Chronic Diarrhea, and reveal a potential new drug for treatment of leishmaniasis, Chagas diseases, and sleeping sickness.
From ASV 2016 at Virginia Tech, Vincent, Rich and Kathy speak with Stephen Russell about his career and his work on oncolytic virotherapy - using viruses to treat cancers.
Hosts: Read More
One of the hallmarks of bad science writing is the claim that any research to do with bacteria will lead to new antibiotics. In this case, however, the scientists backed up their claim. They took bacteria notorious for nosocomial infections (Pseudomonas aeruginosa) and exposed them to a toxin, ... Read More
This episode: Predatory bacteria have a particular protein that protects them from their own prey-damaging enzymes!
(7.3 MB, 7.9 minutes)
Leonilde M. Moreira, PhD, has been studying the Burkholderia complex for 15 years. The bacteria, known for causing pneumonia or septicemia in some individuals, can survive for prolonged periods in moist environments. During the last 10 years, it has become one of the more predominant bacteria se... Read More